Literature DB >> 9673226

Role of a cytotoxic enterotoxin in Aeromonas-mediated infections: development of transposon and isogenic mutants.

X J Xu1, M R Ferguson, V L Popov, C W Houston, J W Peterson, A K Chopra.   

Abstract

Transposon and marker exchange mutagenesis were used to evaluate the role of Aeromonas cytotoxic enterotoxin (Act) in the pathogenesis of diarrheal diseases and deep wound infections. The transposon mutants were generated by random insertion of Tn5-751 in the chromosomal DNA of a diarrheal isolate SSU of Aeromonas hydrophila. Some of the transposon mutants had dramatically reduced hemolytic and cytotoxic activities, and such mutants exhibited reduced virulence in mice compared to wild-type Aeromonas when injected intraperitoneally (i.p.). Southern blot data indicated that transposition in these mutants did not occur within the cytotoxic enterotoxin gene (act). The transcription of the act gene was affected drastically in the transposon mutants, as revealed by Northern blot analysis. The altered virulence of these transposon mutants was confirmed by developing isogenic mutants of the wild-type Aeromonas by using a suicide vector. In these mutants, the truncated act gene was integrated in place of a functionally active act gene. The culture filtrates from isogenic mutants were devoid of hemolytic, cytotoxic, and enterotoxic activities associated with Act. These filtrates caused no damage to mouse small intestinal epithelium, as determined by electron microscopy, whereas culture filtrates from wild-type Aeromonas caused complete destruction of the microvilli. The 50% lethal dose of these mutants in mice was 1.0 x 10(8) when injected i. p., compared to 3.0 x 10(5) for the wild-type Aeromonas. Reintegration of the native act gene in place of the truncated toxin gene in isogenic mutants resulted in complete restoration of Act's biological activity and virulence in mice. The animals injected with a sublethal dose of wild-type Aeromonas or the revertant, but not the isogenic mutant, had circulating toxin-specific neutralizing antibodies. Taken together, these studies clearly established a role for Act in the pathogenesis of Aeromonas-mediated infections.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673226      PMCID: PMC108379     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Classification of enterotoxins on the basis of activity in cell culture.

Authors:  G T Keusch; S T Donta
Journal:  J Infect Dis       Date:  1975-01       Impact factor: 5.226

2.  Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.

Authors:  J W Peterson; W D Dickey; S S Saini; W Gourley; G R Klimpel; A K Chopra
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

3.  Studies on Aeromonas and Plesiomonas species isolated from cases of choleraic diarrhoea.

Authors:  B D Chatterjee; K N Neogy
Journal:  Indian J Med Res       Date:  1972-04       Impact factor: 2.375

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Aeromonas-associated gastroenteritis.

Authors:  M Gracey; V Burke; J Robinson
Journal:  Lancet       Date:  1982-12-11       Impact factor: 79.321

6.  High frequency mobilization of the chromosome of Escherichia coli by a mutant of plasmid RP4 temperature-sensitive for maintenance.

Authors:  S Harayama; M Tsuda; T Iino
Journal:  Mol Gen Genet       Date:  1980

7.  Aeromonas hydrophila toxins - intestinal fluid accumulation and mucosal injury in animal models.

Authors:  A Ljungh; T Kronevi
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

8.  Fatal Aeromonas hydrophila bacteremia in a hemodialysis patient treated with deferoxamine.

Authors:  S H Lin; S D Shieh; Y F Lin; E De Brauwer; H W Van Landuyt; B Gordts; J R Boelaert
Journal:  Am J Kidney Dis       Date:  1996-05       Impact factor: 8.860

9.  Purification and some properties of Aeromonas hydrophila hemolysin.

Authors:  T Asao; Y Kinoshita; S Kozaki; T Uemura; G Sakaguchi
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

10.  Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence.

Authors:  R A Welch; S Falkow
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441

View more
  29 in total

1.  Molecular and functional characterization of a ToxR-regulated lipoprotein from a clinical isolate of Aeromonas hydrophila.

Authors:  Lakshmi Pillai; Jian Sha; Tatiana E Erova; Amin A Fadl; Bijay K Khajanchi; Ashok K Chopra
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

3.  DNA adenine methyltransferase influences the virulence of Aeromonas hydrophila.

Authors:  Tatiana E Erova; Lakshmi Pillai; Amin A Fadl; Jian Sha; Shaofei Wang; Cristi L Galindo; Ashok K Chopra
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  The cytotoxic enterotoxin of Aeromonas hydrophila is aerolysin.

Authors:  J T Buckley; S P Howard
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 5.  Expanding Role of Type II Secretion in Bacterial Pathogenesis and Beyond.

Authors:  Nicholas P Cianciotto; Richard C White
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

6.  Identification and characterization of putative virulence genes and gene clusters in Aeromonas hydrophila PPD134/91.

Authors:  H B Yu; Y L Zhang; Y L Lau; F Yao; S Vilches; S Merino; J M Tomas; S P Howard; K Y Leung
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

7.  Regulation of the cytotoxic enterotoxin gene in Aeromonas hydrophila: characterization of an iron uptake regulator.

Authors:  J Sha; M Lu; A K Chopra
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

8.  The type III secretion system and cytotoxic enterotoxin alter the virulence of Aeromonas hydrophila.

Authors:  Jian Sha; Lakshmi Pillai; Amin A Fadl; Cristi L Galindo; Tatiana E Erova; Ashok K Chopra
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

9.  Type III secretion system genes in clinical Aeromonas isolates.

Authors:  M R Chacón; L Soler; E A Groisman; J Guarro; M J Figueras
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

10.  Molecular characterization of a functional type VI secretion system from a clinical isolate of Aeromonas hydrophila.

Authors:  Giovanni Suarez; Johanna C Sierra; Jian Sha; Shaofei Wang; Tatiana E Erova; Amin A Fadl; Sheri M Foltz; Amy J Horneman; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-24       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.